On Dec. 18, 2017, COFEPRIS announced the approval of 34 innovative medicines for their sale in Mexico. These medications address a vast number of sicknesses affecting the Mexican population, ranging from extremely common diseases, such as diabetes, to rare diseases. Over the course of the next four weeks, we will publish a short summary [...]Read Full Article →